Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade.
Hiraoka A, Kumada T, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). Hiraoka A, et al. Among authors: kawasaki h. Hepatol Res. 2018 Feb;48(3):E61-E67. doi: 10.1111/hepr.12927. Epub 2017 Aug 2. Hepatol Res. 2018. PMID: 28628718
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250. J Gastroenterol Hepatol. 2016. PMID: 26647219
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib.
Hiraoka A, Hirooka M, Koizumi Y, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Abe M, Matsuura B, Kawasaki H, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatol Res. 2017 May;47(6):558-565. doi: 10.1111/hepr.12780. Epub 2016 Aug 30. Hepatol Res. 2017. PMID: 27480045
Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications.
Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K; Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). Hiraoka A, et al. Among authors: kawasaki h. Liver Cancer. 2017 Jun;6(3):204-215. doi: 10.1159/000452846. Epub 2017 Mar 9. Liver Cancer. 2017. PMID: 28626732 Free PMC article.
Zinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virus.
Hiraoka A, Nagamatsu K, Izumoto H, Adachi T, Yoshino T, Tsuruta M, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Suga Y, Mori K, Miyata H, Tsubouchi E, Ninomiya T, Kawasaki H, Hirooka M, Matsuura B, Abe M, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatol Res. 2020 Jan;50(1):92-100. doi: 10.1111/hepr.13430. Epub 2019 Nov 24. Hepatol Res. 2020. PMID: 31729124
Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2010 Feb;25(2):403-7. doi: 10.1111/j.1440-1746.2009.06037.x. Epub 2009 Nov 19. J Gastroenterol Hepatol. 2010. PMID: 19929922
Hepatic resection assisted by ablative therapy for advanced hepatocellular carcinoma.
Hiraoka A, Tazuya N, Hidaka S, Uehara T, Ichiryu M, Nakahara M, Tanabe A, Shimizu Y, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Kawasaki H, Ochi H, Koizumi Y, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2011 May-Jun;58(107-108):955-9. Hepatogastroenterology. 2011. PMID: 21830423
Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy.
Hiraoka A, Kawamura T, Aibiki T, Okudaira T, Toshimori A, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Murakami T, Ishimaru Y, Kawasaki H, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Eur J Radiol. 2015 Mar;84(3):366-371. doi: 10.1016/j.ejrad.2014.11.038. Epub 2014 Dec 15. Eur J Radiol. 2015. PMID: 25554005
Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Hiraoka A, Ishimaru Y, Kawasaki H, Aibiki T, Okudaira T, Toshimori A, Kawamura T, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Oncology. 2015;89(3):167-74. doi: 10.1159/000381808. Epub 2015 May 12. Oncology. 2015. PMID: 25999038
2,363 results